Covid-19
Germany approves clinical trial of coronavirus immunity vaccines
Germany has approved clinical trials of multiple vaccines developed by German biotech company, BioNTech, for treatment of coronavirus. Scientists were said to be monitoring the effectiveness of the vaccines in generating immunity against coronavirus. The clinical trial will be starting with 200 participants of 18 to 55 years age bracket.
Statistics from Johns Hopkins University shows that coronavirus has killed over 177,000 people and infected 2.5 million across the world. This was identified to have given impetus to the race to develop vaccines that can contain the spread of coronavirus and the associated deaths across the world.
About 86 teams were identified to be engaged on research and study for coronavirus vaccines across the world.
-
Latest4 days agoMakinde declares 2027 presidential bid under PDP–APM alliance
-
Business3 days agoNigeria: Whither the fruits of 2026 crude oil windfall?
-
Comments and Issues4 days agoPolitical Parties Primaries: Consensus or Coronation?
-
Featured4 days agoObasanjo faults Tinubu’s economic reforms, calls them necessary but poorly designed
-
Business5 days agoAnger, debate trail proposed $1.25bn loan amid concerns over Nigeria’s debt surge
-
Business2 days agoTrump-Xi summit sparks fresh questions for Nigeria’s economy, tech sector
-
Featured4 days agoWike dismisses political speculation over meeting with APC Chairman Yilwatda
-
Latest4 days agoWike says Makinde’s presidential ambition dead on arrival